Brain zaps may curb smoking cravings in HIV patients
NCT ID NCT05295953
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether a non-invasive brain stimulation technique called TMS could reduce smoking cravings and attention to cigarette cues in people living with HIV/AIDS. Four participants received either real or sham TMS sessions. The goal was to see if TMS could help them focus less on smoking triggers and feel less urge to smoke.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcranial magnetic stimulation (TMS)
- What this could lead to
- If it works, this could point toward a new way to help people with HIV/AIDS quit smoking by reducing cravings.
- What could go wrong
- This was a very small early study with only 4 participants, so results may not apply to others. It only measured short-term effects on cravings and attention, not actual quitting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
245 Fountain Court
Lexington, Kentucky, 40513, United States
-
University of Kentucky
Lexington, Kentucky, 40513, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?